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Many factors have been linked to the failure of chemotherapy as
an effective treatment for cancer. One of the major obstacles to the
success of chemotherapy is drug resistance at the cellular level.
Drug resistance can be innate or acquired and often becomes
apparent on exposure to a single cytotoxic agent, which selects
cells resistant to other functionally and structurally unrelated drugs
(reviewed by Ling, 1992). This phenomenon is termed multidrug
resistance and is commonly associated with overexpression of the
170 kDa ATP-dependent drug efflux pump termed P-glycoprotein
(P-gp), encoded by the MDR1 gene in humans. P-glycoprotein
reduces the intracellular concentration of drug by actively
increasing cellular drug efflux. In light of this, the approach most
extensively employed in an attempt to circumvent multidrug resis-
tance has involved the use of resistance modifiers such as vera-
pamil to reverse P-gp function. However, so far this approach has
had limited clinical impact (reviewed by Volm, 1998).
Other changes have been reported in multidrug-resistant (MDR)
cells in addition to P-gp overexpression. These changes suggest an
alternative approach to circumvent multidrug resistance by
exploiting these biochemical differences to eradicate MDR cells
preferentially. One such difference involves changes in metabo-
lism, such as the increased levels of glycolysis shown by some
MDR cells (Cohen and Lyon, 1987). Previous results from this
laboratory have shown that MDR variants of the KB carcinoma
cell line were preferentially sensitive to the effects of the
glycolytic inhibitor 2-deoxy-D-glucose (Bentley et al, 1996) and to
tunicamycin (Bentley et al, 1997), which in the former case was
shown to be via an induction of apoptosis (Bell et al, 1998).
A recent report has suggested that accumulation of the glycosph-
ingolipid glucosylceramide is a feature of MDR cells, which may be
a requirement for the acquisition and/or maintenance of multidrug
resistance (Lavie et al, 1996). This phenomenon has also recently
been observed in a limited study in patients with melanoma (stage
IV) and breast cancer (stage IV), where measurable levels of gluco-
sylceramide were detected in tumour specimens from patients who
failed chemotherapy, but not in those from patients with a clinical
response following chemotherapy (Lucci et al, 1998).
Glucosylceramide is formed from ceramide, by the action of the
enzyme glucosylceramide synthase, which mediates the transfer of
UDP-glucose to ceramide. Glucosylceramide is further glycosyl-
ated to other higher gangliosides and glycolipids or is degraded by
glucocerebrosidase (Marsh et al, 1995). Ceramide, the precursor of
glucosylceramide, is recognized as a second messenger involved
in the induction of apoptosis, although this view has recently been
challenged (Hoffman and Dixit, 1998). Generation of ceramide
through the sphingomyelin-signalling pathway occurs in response
to the post-receptor action of a variety of cytokines, hormones and
growth factors (Jarvis et al, 1996). These include members of the
tumour necrosis factor (TNF) superfamily, Fas/Apo-1 ligand,
interleukin-1 and 1,25-dihydroxyvitamin D3. On activation of the
corresponding receptors, sphingomyelin is hydrolysed to ceramide
and phosphorylcholine by the action of a sphingomyelinase.
Alternatively, de novo synthesis of ceramide occurs from sphingo-
sine mediated by the enzyme ceramide synthase (Luberto et al,
1998). Among the intracellular targets of ceramide are a ceramide-
activated protein kinase (CAPK; Mathias et al, 1991), ceramide-
activated protein phosphatase (CAPP; Dobrowsky and Hannun,
1992) and protein kinase Cx (Lozano et al, 1994).
Inhibitors of glucosylceramide synthase have been well-
documented and include PDMP (1-phenyl-2-decanoylamino-3-
morpholino-1-propanol), (Figure 1), which causes the accumulation
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Summary This study has compared the preferential killing of three multidrug-resistant (MDR) KB cell lines, KB-C1, KB-A1 and KB-V1 by two
inhibitors of glucosylceramide synthase, 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and 1-phenyl-2-hexadecanoylamino-3-
pyrrolidino-1-propanol (PPPP), to the killing produced by these compounds in the drug-sensitive cell line, KB-3-1. Both of the inhibitors caused
much greater induction of apoptosis in each of the three MDR cell lines than in the drug-sensitive cell line, as judged by morphological assay
and confirmed by poly-(ADP-ribose)-polymerase cleavage. The highest level of apoptosis was produced following 24-h exposure to
5 mM PPPP. This treatment produced 75.8 (± 7.1)%, 73.6 (± 9.8)% and 75.3 (± 6.4)% apoptotic cells in the three MDR cell lines respectively,
compared to 19.0 (± 9.8)% in the drug-sensitive cell line. A reduction in glucosylceramide level following inhibitor treatment occurred in
KB-3-1 cells as well as in the MDR cell lines, suggesting that the increased apoptotic response in the MDR cells reflected a different
downstream response to changes in the levels of this lipid in these cells compared to that in the drug-sensitive cells. These results suggest that
the manipulation of glucosylceramide levels may be a fruitful way of causing the preferential killing of MDR cells in vitro and possibly in vivo.
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1993), and PPPP (1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-
propanol), (Figure 1), which has been reported to only cause a
reduction in glucosylceramide without affecting ceramide levels
(Abe et al, 1995). PDMP was synthesized as a specific treatment for
Gaucher’s disease in which patients have increased levels of gluco-
sylceramide due to a lack of glucocerebrosidase (Radin, 1996). In
addition, preliminary studies designed to assess the efficacy of
PDMP as an anticancer agent demonstrated that mice inoculated
with Ehrlich ascites carcinoma cells and treated with PDMP had an
increased lifespan in relation to control mice (Radin, 1994). In
another study using rats with C6 glial tumours, PDMP reduced
tumour size (Radin, 1994). PPPP was rationally designed based on
the structure of PDMP, in which the morpholine group in PDMP has
been substituted by a pyrrolidine group to increase the specificity
and efficacy of PPPP as an inhibitor of glucosylceramide synthase
(Abe et al, 1995).
This present study was designed to investigate the effect of
inhibitors of ceramide metabolism on MDR cells in view of the
evidence of increased glucosylceramide accumulation in MDR cells.
An additional aim was to determine the nature of any preferential cell
killing effect of these inhibitors in terms of induction of apoptosis or
necrosis, as understanding the mechanism of killing of MDR cells by
these agents will be of value in optimizing the process. From this
study it is apparent that altering ceramide metabolism with PDMP
and PPPP has a preferential killing effect on MDR KB cells. These
findings suggest that the maintenance of glucosylceramide levels
may be of greater significance in preventing apoptosis in MDR cells
than in their normal counterparts.
MATERIALS AND METHODS
Cell culture
The human KB carcinoma drug-sensitive cell line, KB-3-1, and its
MDR derivative cells, KB-C1, KB-A1 and KB-V1, selected in
colchicine, doxorubicin and vinblastine respectively, were
obtained from Dr MM Gottesman (National Cancer Institute,
Bethesda, MD, USA) or the American Type Culture Collection.
Cells were maintained in 25-cm2 flasks in Dulbecco’s modified
Eagle’s medium (DMEM; Gibco) containing 0.11 g l–1 sodium
pyruvate and 4.5 g l–1 glucose, supplemented with 10% fetal calf
serum (v/v), penicillin (32 mg ml–1) and streptomycin (50 mg ml–1).
The MDR variants of the KB cell lines were maintained in the
presence of 1 mg ml–1 of the selecting agent. Cells were grown as
monolayers and were incubated at 37°C in a humidified atmos-
phere of 95% air/5% carbon dioxide. Cells were grown in the
absence of selecting agent during each experiment.
DL-threo-PDMP (Calbiochem) was dissolved in isopropanol to
a concentration of 50 mM and was further diluted to working
concentrations by the addition of DMEM. DL-threo-PPPP
(Calbiochem) was dissolved in dimethyl sulphoxide to a concen-
tration of 100 mM and was further diluted to working concentra-
tions by the addition of DMEM. The final concentration of
solvents used was not found to be cytotoxic to the cells.
Colony formation assay
KB-3-1 and its MDR derivatives were incubated in 6-well plates
in the presence of PDMP or PPPP for 24 h. Cell survival was
measured by a colony-forming assay, in which cells were re-plated
at a density of between 100 and 300 cells per well in 24-well
plates, depending on the plating efficiency of the cell line, for a
further 8 days before staining with Leishman’s stain (0.2% in
methanol). Colonies of over 50 cells were counted, and survival
was expressed as colony forming ability after treatment with
inhibitor relative to that of untreated controls.
Morphological assessment of apoptosis induction in
cells exposed to PDMP and PPPP
Cells were plated at an initial cell density of 4 ´ 104 cells per well
in 6-well plates for 2 days. DMEM was removed and replaced
with PPPP or PDMP. Following a specific exposure time all cells
(detached and adherent) were harvested and were labelled with
annexin-V–FITC (fluoroscein isothiocyanate; final concentra-
tion 4 mg ml–1) in annexin binding buffer (10 mM HEPES pH 7.4,
150 mM sodium chloride, 5 mM potassium chloride, 1 mM magne-
sium chloride and 1.8 mM calcium chloride), Hoechst 33342 (final
concentration 16 mg ml–1) and propidium iodide (final concentra-
tion 10 mg ml–1). Cells were viewed under a fluorescence micro-
scope (Zeiss) using a UV filter (365 nm) for viewing Hoechst
33342 and propidium iodide staining and a blue filter (450–
490 nm) for annexin-V–FITC and propidium iodide staining.
Three hundred cells per sample were counted in triplicate for each
time point. Cells were scored as viable, apoptotic and necrotic as
judged by nuclear morphology, membrane integrity and phospha-
tidylserine externalization. Viable cells were blue and the nucleus
was diffuse and intact. Apoptotic cells were divided into early and
late apoptotic; early apoptotic cells were blue since they maintain
their membrane integrity and exclude propidium iodide, however
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Figure 1 The structure of (A) PDMP and (B) PPPPthe nucleus appeared fragmented and condensed. Late apoptotic
cells were similar in appearance to early apoptotic cells although
they appeared pink since membrane integrity is lost as a late
feature of apoptosis and thus the cells were able to take up
propidium iodide. Necrotic cells were also pink in appearance, the
cells were often enlarged and the nucleus was diffuse and intact.
Viewing cells under a blue filter for annexin-V–FITC binding
demonstrated that only the apoptotic cells had a visible green
plasma membrane indicative of annexin-V–FITC binding to exter-
nalized phosphatidylserine. Externalization of phosphatidylserine
is an early apoptotic event, which precedes nuclear changes
(Martin et al, 1995). Viable and necrotic cells had no annexin-
V–FITC staining present. (See Bell et al (1998) for photographic
examples of each cell type.) A t-test was used to determine signifi-
cance between values for MDR and sensitive cells.
Western blot analysis of poly-(ADP-ribose)-polymerase
(PARP) cleavage in cells exposed to PDMP or PPPP
Cells were seeded in 25-cm2 flasks at a density of 2 ´ 105 cells and
were incubated for 2 days at 37°C. DMEM was removed and
replaced with 5 mM PPPP or 75 mM PDMP for various times of
exposure. Cell lysates were prepared in sample buffer (30 mM
Tris–HCl pH 7.8, 9% sodium dodecyl sulphate (SDS), 0.1 mM
PMSF) and protein was determined using a BCA-protein assay
(Pierce). SDS polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blotting was performed by loading 30 mg protein per
sample on to a 10% polyacrylamide gel using a standard procedure
(Laemmli et al, 1970). The primary antibody (rabbit anti-PARP,
Boehringer Mannheim) was diluted 1:2000 and the secondary anti-
rabbit IgG horseradish-peroxidase antibody was diluted 1:5000.
Bands corresponding to intact PARP and its cleavage product (113
and 89 kDa respectively) were detected by enhanced chemi-
luminescence (ECL kit, Amersham).
Lipid extraction and thin layer chromatography
Total cellular lipids were extracted from 2 ´ 107 cells with chloro-
form/methanol (2:1 by volume). After sample separation into two
phases, the lower organic phase containing the lipids was collected
and a second extraction was performed with a synthetic aqueous
phase (chloroform/methanol/0.1 M potassium chloride, 6:47:47 by
volume). The lower organic phase was collected and evaporated to
dryness and the resulting lipids were resuspended in chloroform.
Lipids were applied to silica gel 60 TLC plates (Merck) on an equal
total lipid basis and were run in a solvent system consisting of
chloroform/methanol/ammonium hydroxide (70:20:4 by volume)
against standards of ceramide (Sigma) and glucosylceramide
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Figure 2 The effect of exposure to PDMP or PPPP on KB cell lines. KB-3-1 cells were exposed to increasing concentrations of PDMP (A) or PPPP (C) and
KB-C1 cells were exposed to PDMP (B) or PPPP (D) for 24 h. The percentage of viable (•), apoptotic (n) and necrotic cells (s) was determined by assessing
nuclear morphology, membrane integrity and phosphatidylserine externalization using Hoechst 33342, propidium iodide and annexin-V–FITC. Each point
represents the mean of triplicate values from three independent experiments ± standard deviation(Sigma). Plates were air dried for 1 h before spraying with 35%
sulphuric acid in water. Lipids were visualized by charring the plate
at 160°C for 20 min.
RESULTS
Induction of apoptosis in MDR cell lines by PDMP and
PPPP
Initial studies were performed to assess the effects of different
concentrations of PDMP and PPPP on the levels of apoptosis and
necrosis in normal and MDR cells. KB-3-1 and KB-C1 cells were
plated in PDMP (30, 50 or 75 mM) or PPPP (1, 2.5 or 5 mM) for 24 h
before the cells were harvested and labelled with Hoechst 33342,
propidium iodide and annexin-V–FITC. Cells were scored as
viable, apoptotic and necrotic on the basis of their nuclear
morphology, membrane integrity and phosphatidylserine external-
ization. Figure 2 shows the effect of increasing inhibitor concentra-
tion on each cell line. The basal levels of apoptosis and necrosis in
both cell lines were approximately 5% and 10% respectively.
Increasing the concentration of PDMP in KB-3-1 cells increased
the level of apoptosis only slightly and had no significant effect on
the levels of necrosis. In contrast, increasing the concentration of
PDMP in the KB-C1 cell line resulted in a marked dose-dependent
increase in apoptosis to a maximum in 75 mM. Similarly, all
concentrations of PPPP induced much higher levels of apoptosis in
KB-C1 than in KB-3-1. On the basis of these results, it was decided
to use concentrations of 75 mM PDMP and 5 mM PPPP in subse-
quent studies.
MDR cell lines selected in different drugs are known to have
differences in cellular properties, including differing cross-
resistance patterns (see, for example, Table 1 in Bell et al (1998)).
Therefore, in order to broaden the significance of this work, all
subsequent experiments were performed with the MDR cell lines
KB-A1 and KB-V1, in addition to KB-C1. Initially, the effects of
24-h exposure to 75 mM PDMP or 5 mM PPPP on the cell survival
of each of these three MDR cell lines was compared to that of the
sensitive cell line KB-3-1. At the end of the 24-h exposure to
the inhibitors, cell survival was determined by a colony-forming
assay, performed in drug-free medium. In all cases, the inhibitors
produced a much greater reduction in colony-forming ability in the
MDR cell lines than in the sensitive cell line (Table 1). The effect
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Figure 3 A time course of apoptosis induction by 75 mM PDMP in (A) KB-3-1, (B) KB-C1, (C) KB-A1 and (D) KB-V1 cells as assessed by nuclear morphology,
phosphatidylserine externalization and membrane integrity using Hoechst 33342, propidium iodide and annexin-V–FITC. Cells were scored as viable (•),
apoptotic (n) or necrotic (s). Each point represents the mean of triplicate values from three independent experiments ± standard deviationwas much more pronounced following treatment with 5 mM PPPP
than with 75 mM PDMP. The greatest effect was on KB-A1, where
treatment with PPPP for 24 h reduced cell survival to below 2%.
The levels of apoptosis and necrosis were then determined at
various times of exposure to 75 mM PDMP up to 24 h in KB-3-1
and the three MDR KB cell lines. In KB-3-1 cells apoptosis and
necrosis did not appear to increase over time (Figure 3). In all the
MDR cell lines, apoptosis increased steadily over time concomitant
with a reduction in the proportion of viable cells beginning after
approximately 4 h of drug exposure. In all three MDR cell lines
necrosis was not significantly altered over time of exposure.
Maximum levels of apoptosis obtained following a 24-h exposure
to PDMP were 34.8 ± 9.7% for KB-C1, 43.5 ± 16.9% for KB-A1
and 54.6 ± 16.3% for KB-V1 cells (Table 2) indicating that of the
three MDR cell lines tested, KB-V1 cells were most susceptible to
the effects of PDMP.
Cells were exposed to 5 mM PPPP for 24 h and the levels of
viable, apoptotic and necrotic cells are presented in Table 3. Levels
of apoptosis were significantly higher in the MDR cells than in
KB-3-1 cells with values of 75.8 ± 7.1% for KB-C1, 73.6 ± 9.8%
for KB-A1 and 75.3 ± 6.4% for KB-V1 cells obtained. In contrast,
necrosis did not increase in relation to control values in any cell
line. These results demonstrate that all three MDR cell lines exhib-
ited similar high levels of sensitivity to PPPP and were more
susceptible to the effects of PPPP than PDMP.
PARP cleavage following exposure to PDMP or PPPP
The cleavage of the enzyme PARP was assessed as a second
measure of apoptosis in addition to the cytological studies. PARP is
cleaved in some cell lines by interleukin converting enzyme-like
proteases as an early event in the induction of apoptosis from a
113 kDa protein into two fragments of 89 kDa and 24 kDa
(Kaufmann et al, 1993). Cell lysates were prepared following a
timed exposure to either inhibitor up to 24 h and the cleavage of
PARP associated with the appearance of the 89 kDa cleavage
product assessed by Western blotting. In KB-3-1 cells exposed to
PDMP, no cleavage was detected after the maximum exposure of 24
h as determined by the absence of the 89 kDa band (Figure 4). In
KB-C1 cells PARP was cleaved following a 2 h exposure to PDMP.
In KB-A1 and KB-V1 cells exposed to PDMP, PARP was cleaved
following a 4 h exposure. Cells exposed to PPPP and analysed for
PARP cleavage are shown in Figure 5. As with PDMP, KB-3-1 cells
exposed to PPPP for up to 24 h did not exhibit any PARP cleavage.
In contrast, the three MDR cell lines studied showed PARP cleavage
following exposure to PPPP for 2 h (KB-V1) or 8 h (KB-C1 and
KB-A1). It is interesting to note that in the KB-V1 cell line only the
cleavage fragment remained after a 24-h exposure to PPPP.
Lipid analysis following exposure to PDMP and PPPP
Total cell lipids were extracted as described and were run on silica
60 thin layer chromatography (TLC) plates to resolve the different
lipids. From Figure 6 it is clear that glucosylceramide was a minor
lipid component of KB cells; although it was present at slightly
higher levels in KB-A1 and KB-V1, an increase was not observed
in KB-C1 cells in comparison to KB-3-1. Ceramide levels
appeared to be similar in all four cell lines, although the possibility
of other lipids co-migrating with ceramide has not been elimi-
nated. Figure 7 shows the results produced following TLC of
whole cell lipids in control and PDMP-treated cells. The level of
glucosylceramide was reduced in each cell line by PDMP. This
occurred concomitantly with a slight increase in ceramide levels in
all cell lines except KB-A1. The most consistent and striking
difference on treatment with PDMP related to an increase in a
different lipid component which at present remains unidentified,
but from studies using other lipid standards it has been demon-
strated that this lipid was not sphingomyelin, sphingosine or
sphinganine (data not shown).
The effect of the more specific inhibitor, PPPP on cellular lipids
in KB cells is shown in Figure 8. PPPP treatment resulted in the
absence of glucosylceramide in all the cell lines. An increase in
ceramide levels was not detected in any cell line following treatment
Preferential killing of MDR cells by apoptosis 427
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Figure 4 Western blot of the cleavage of the enzyme poly-(ADP-ribose)-
polymerase by PDMP. KB-3-1 (A), KB-C1 (Bi and Bii), KB-A1 (C) and KB-V1
(D) cells were exposed to 75 mM PDMP for up to 24 h. Numbers above lanes
represent time of exposure (h) to PDMP. Untreated control cells (c) were
harvested at 24 h. Arrows indicate intact PARP (113 kDa) and the cleavage
product (89 kDa)
Table 1 Percentage survival of KB-3–1, KB-C1, KB-A1 and KB-V1 cells
following a 24-h exposure to 75 mM PDMP or 5 mM PPPP
Cell line Mean % survival ± s.d. Mean % survival ± s.d.
after PDMP treatment after PPPP treatment
KB-3-1 67.7 ± 6.2 63.4 ± 1.0
KB-C1 31.9 ± 9.4b 10.5 ± 2.5c
KB-A1 42.7 ± 2.5b 1.7 ± 1.2c
KB-V1 36.2 ± 10.8a 17.6 ± 0.6c
Survival was determined using a colony formation assay by re-plating of the
cells in drug-free medium for 8 days. Colonies of more than 50 cells were
counted and the effect of PDMP or PPPP on colony forming ability compared
to drug-free controls. Level of significance of the difference of the value for
each MDR cell line is given in comparison to that for KB-3-1 (aP < 0.05, bP <
0.01, cP < 0.001).with PPPP. Exposure to PPPP had a much less pronounced effect
on the levels of the unidentified lipid which had been observed
following PDMP treatment.
DISCUSSION
This study has investigated the preferential killing of three KB
MDR cell lines following exposure to two inhibitors of ceramide
metabolism, PDMP and PPPP. It has been shown that there is a
substantially greater killing of all the three MDR cell lines than in
sensitive cells by exposure to either of the inhibitors, and that this
preferential killing of MDR cells is due to the greater suscepti-
bility to induction of apoptosis in these MDR lines. In accord with
this finding, both drugs induce much greater PARP cleavage in the
MDR cell lines than in KB-3-1. The three MDR cell lines had
previously been shown to undergo apoptosis much more readily
than sensitive cells when exposed to 2-deoxy-D-glucose (Bell et al,
1998). The present study, with a completely different class of
agent, now suggests that the MDR cells may be preferentially
sensitive to the induction of apoptosis by a wide range of stimuli.
We have shown that the effects of PDMP and PPPP on ceramide
metabolism in all of our cell lines are broadly as would be expected
from published observations in other cell systems. It has been
previously reported that, although both are inhibitors of glucosyl-
ceramide synthase, PDMP results in a decrease in glucosyl-
ceamide levels and an increase in ceramide levels, whereas PPPP
also results in a decrease in glucosylceramide levels, without a
detectable increase in ceramide levels (Abe et al, 1995). The differ-
ence between the effects of the two inhibitors is thought to be due
to PDMP having a less specific effect on a number of other
enzymes involved in ceramide metabolism. In the present work, we
have observed that both of the inhibitors reduced glucosylceramide
levels in all the cell lines. PDMP treatment resulted in a detectable
increase in ceramide levels in several and a marked increase in an
428 KM Nicholson et al
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Figure 5 Western blot of the cleavage of the enzyme poly-(ADP-ribose)-
polymerase by PPPP. KB-3-1 (A), KB-C1 (B), KB-A1 (C) and KB-V1 (D) cells
were exposed to 5 mM PPPP for up to 24 h. Numbers above lanes represent
time of exposure (h) to PPPP. Untreated control cells (c) were harvested at
24 h. Arrows indicate intact PARP (113 kDa) and the cleavage product
(89 kDa)
Figure 6 Thin layer chromatogram of total cell lipids in untreated KB-3-1
(lane 2), KB-C1 (lane 3), KB-A1 (lane 4) and KB-V1 (lane 5) cells against a
glucosylceramide standard (lane 1) and a ceramide standard (lane 6). Equal
lipids were applied to the TLC plate and the lipids resolved in a solvent
system consisting of chloroform/methanol/ammonium hydroxide (70:20:4 by
volume). Glucosylceramide (a) and ceramide (b) are indicated by arrows
123 4 5 6
b
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Table 2 Induction of apoptosis in KB cells following exposure to PDMP
Cell line Mean % of cells ± s.d.
Viable Apoptotic Necrotic
KB-3-1 77.1 ± 6.2 13.7 ± 4.7 9.2 ± 4.7
KB-C1 53.8 ± 11.6a 34.8 ± 9.7a 11.7 ± 4.1
KB-A1 49.5 ± 16.2a 43.5 ± 16.9a 7.0 ± 2.4
KB-V1 38.5 ± 16.1a 54.6 ± 16.3a 7.5 ± 2.0
Cells were exposed to 75 mM PDMP for 24 h before harvesting and staining
with propidium iodide, Hoescht 33342 and annexin-V-FITC. The percentage
of viable, apoptotic and necrotic cells in each sample were assessed in
triplicate. Results were expressed as a mean percentage of cells ± s.d. of
three independent experiments. Significance of the value for MDR cells is
given in relation to KB-3-1 cells (aP < 0.001).
Table 3 Induction of apoptosis in KB cells following exposure to PPPP
Cell line Mean % of cells ± s.d.
Viable Apoptotic Necrotic
KB-3-1 72.1 ± 10.0 19.0 ± 9.8 8.8 ± 2.2
KB-C1 16.2 ± 5.8a 75.8 ± 7.1a 8.0 ± 2.1
KB-A1 20.4 ± 9.9a 73.6 ± 9.8a 6.1 ± 1.8
KB-V1 18.8 ± 5.0a 75.3 ± 6.4a 6.0 ± 2.3
Cells were exposed to 5 mM PPPP for 24 h before harvesting and staining
with propidium iodide, Hoescht 33342 and annexin-V–FITC. The percentage
of viable, apoptotic and necrotic cells in each sample were assessed in
triplicate. Results were expressed as a mean percentage of cells ± s.d. of
three independent experiments. Significance of the value of MDR cells is
given in relation to KB-3-1 cells (aP < 0.001).unidentified lipid in all cell lines. In contrast, exposure to PPPP did
not produce a detectable effect on ceramide levels in any of the cell
lines, and had a much lesser effect than PDMP on the level of the
unidentified lipid. Thus, as would be expected, PPPP has had a
much more specific effect on glucosylceramide levels than PDMP.
The reduction in glucosylceramide level following inhibitor
treatment occurred in KB-3-1 cells as well as in the MDR cell
lines. Our results therefore suggest that maintenance of glucosyl-
ceramide levels are of much greater importance in preventing
apoptosis in MDR cells than in their sensitive counterparts. This
implies that the higher level of apoptosis, which is finally observed
in response to the inhibitors in the MDR cells is due to a greater
downstream susceptibility to changes in glucosylceramide levels
in these cells. Glycosphingolipids such as glucosylceramide are
known to have a role in cell growth and proliferation (Hannun and
Bell, 1989; Rani et al, 1995), although their role in apoptosis is
poorly defined. There are clear differences in the induction of
PARP cleavage in all our MDR cell lines compared to KB-3-1,
suggesting a difference in response in the MDR cells lies between
glucosylceramide levels and PARP cleavage.
It is of interest that Lavie et al (1996) have previously reported
elevated levels of glucosylceramide in three MDR cell lines
(MCF-7-ADR, KB-V1 and OVCAR-3) in comparison to the
levels in their sensitive parental cells and Lucci et al (1998) have
suggested that elevated levels of glucosylceramide may be a
convenient general marker by which to recognize MDR clinical
samples. Our finding that glucosylceramide levels are increased
in KB-V1 and KB-A1 is consistent with Lavie’s observation,
although the absence of such an increase in KB-C1 suggests that
elevation of glucosylceramide levels may not be a universal
feature of all MDR cell lines. (However, KB-C1 was selected in
the presence of colchicine and therefore, overall, the data is still
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Figure 7 (A) Thin layer chromatogram of total cell lipids in untreated
KB-3-1 (lane 2) and untreated KB-C1 cells (lane 4). Lanes 3 and 5 represent
total cell lipids from KB-3-1 and KB-C1 cells respectively following exposure
to 75 mM PDMP for 24 h. (B) Thin layer chromatogram of total cell lipids in
untreated KB-A1 (lane 2) and untreated KB-V1 cells (lane 4). Lanes 3 and 5
represent total cell lipids from KB-A1 and KB-V1 cells respectively following
exposure to 75 mM PDMP for 24 h. Samples were run against a
glucosylceramide standard (lane 1) and a ceramide standard (lane 6). Equal
lipids were applied to the TLC plate and the lipids resolved in a solvent
system consisting of chloroform/methanol/ammonium hydroxide (70:20:4 by
volume). Glucosylceramide (a), ceramide (b) and the unknown lipid (c) are
indicated by arrows
Figure 8 (A) Thin layer chromatogram of total cell lipids in untreated
KB-3-1 (lane 2) and untreated KB-C1 cells (lane 4). Lanes 3 and 5 represent
total cell lipids from KB-3-1 and KB-C1 cells respectively following exposure
to 5 mM PPPP for 24 h. (B) Thin layer chromatogram of total cell lipids in
untreated KB-A1 (lane 2) and untreated KB-V1 cells (lane 4). Lanes 3 and 5
represent total cell lipids from KB-A1 and KB-V1 cells respectively following
exposure to 5 mM PPPP for 24 h. Samples were run against a
glucosylceramide standard (lane 1) and a ceramide standard (lane 6). Equal
lipids were applied to the TLC plate and the lipids resolved in a solvent
system consisting of chloroform/methanol/ammonium hydroxide (70:20:4 by
volume). Glucosylceramide (a), ceramide (b) and the unknown lipid (c) are
indicated by arrows
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123456consistent with the view that MDR cells which have been selected
in the presence of those agents, which are clinically relevant
do appear to have elevated glucosylceramide.) If, as we are
suggesting here, that MDR cells are more sensitive to depletion
of glucosylceramide than their non-MDR counterparts, observed
increases in glucosylceramide in MDR cells may well have been
selected as a buffering mechanism against fluctuations in gluco-
sylceramide during cell growth or exposure to stress.
Our findings suggest that manipulation of glucosylceramide
levels may be a fruitful way of causing the preferential killing of
MDR cells. Further studies on the biochemical basis of the greater
susceptibility to reduction of glucosylceramide in MDR cells may
offer further insight into novel approaches to maximizing their
preferential killing in vitro and possibly in vivo. It may be of
particular interest to examine the combined effects of glucosyl-
ceramide synthase inhibitors and other cytotoxic agents on the
preferential killing of MDR cells.
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